Navicixizumab Uses, Dosage, Side Effects and more
Navicixizumab is under investigation in clinical trial NCT02298387 (A Phase 1 Study of Navicixizumab in Subjects With Solid Tumors).
| Attribute | Details |
|---|---|
| Trade Name | Navicixizumab |
| Generic | Navicixizumab |
| Navicixizumab Other Names | Navicixizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
